The report "Phototherapy Equipment Market by Product (Conventional Phototherapy Equipment, Fiber-Optic Phototherapy Equipment), Application (Neonatal Jaundice, Skin Diseases (Psoriasis, Vitiligo)), End User (Hospitals, Homecare Settings) - Global Forecast to 2031",is projected to grow from USD 0.47 billion in 2026 and to reach USD 0.62 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Browse 250 market data tables and 100 figures spread through 300 pages and in-depth TOC on "Phototherapy Equipment Market by Product (Conventional Phototherapy Equipment, Fiber-Optic Phototherapy Equipment), Application (Neonatal Jaundice, Skin Diseases (Psoriasis, Vitiligo)), End User (Hospitals, Homecare Settings) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/phototherapy-equipment-market-174360683.html
The rising demand for portable and home-based healthcare solutions is driving growth in the phototherapy equipment market. Devices like wearable bilirubin blankets and compact dermatology units enable treatment outside hospitals, reducing stays. This is especially helpful in neonatal care, allowing parents to manage jaundice at home with medical supervision and avoid readmissions. In dermatology, home-use phototherapy options offer patients a convenient way to treat chronic skin conditions, improving adherence. The move towards decentralized healthcare, aided by telemedicine and remote monitoring, further boosts adoption. Portable systems are also increasingly popular in rural and underserved areas where access to advanced healthcare is limited. As healthcare systems worldwide aim to cut costs and focus on patient-centered care, the demand for flexible, accessible phototherapy solutions is set to rise.
“Conventional phototherapy equipment accounted for the largest share of the market in 2025.”
The widespread adoption of conventional phototherapy equipment in developing regions such as India, China, and parts of Africa significantly contributes to its leading market share. These regions often face constraints related to healthcare budgets, infrastructure, and access to advanced medical technologies. Conventional phototherapy systems, with their affordability and minimal infrastructure requirements, are well-suited to such environments. Many hospitals and primary healthcare centers in these regions rely on basic yet effective medical equipment to address high patient volumes. Additionally, international health organizations and government initiatives aimed at reducing neonatal mortality frequently procure conventional phototherapy units due to their cost efficiency and ease of deployment. The high incidence of neonatal jaundice in these densely populated regions further drives demand. Furthermore, local manufacturing capabilities in countries like India and China enable the production of low-cost systems, enhancing accessibility. This strong foothold in emerging markets ensures sustained demand and reinforces the segment’s dominance globally.
“Neonatal jaundice accounted for the majority of market share in 2025.”
The global increase in birth rates, particularly in emerging economies, is a key factor driving the demand for neonatal care solutions, including phototherapy equipment. Alongside this, there has been a noticeable rise in preterm births, which are more prone to developing severe jaundice due to underdeveloped liver function. Preterm infants often require prolonged monitoring and treatment, increasing the utilization of phototherapy devices in NICUs. Countries in the Asia Pacific and Africa, with high birth rates and improving healthcare access, are witnessing a surge in demand for neonatal treatment infrastructure. Additionally, lifestyle factors, maternal health conditions, and increased use of assisted reproductive technologies have contributed to higher incidences of premature births globally. This expanding neonatal population directly increases the patient pool requiring treatment for jaundice. As hospitals and healthcare systems scale up their capacity to manage newborn complications, the procurement and deployment of phototherapy equipment continue to rise, supporting the segment’s leading market position.
“Asia Pacific to exhibit the highest growth rate in the phototherapy equipment market during the forecast period.”
Asia Pacific has the highest birth rate globally, particularly in countries such as India and China, which together account for a substantial share of annual global births. This large neonatal population directly increases the incidence of neonatal jaundice, a condition affecting a majority of newborns to varying degrees. Since phototherapy is the standard and most widely recommended treatment for hyperbilirubinemia, the demand for phototherapy equipment rises proportionately with birth volumes. Additionally, improving access to healthcare services has led to higher diagnosis rates, further expanding the treated patient pool. The increasing survival rate of preterm and low-birth-weight infants—who are more susceptible to jaundice—also contributes to demand. As healthcare systems strengthen their neonatal care capabilities, hospitals are compelled to equip themselves with reliable phototherapy systems. This continuously expanding patient base ensures sustained growth and is a primary factor behind the region’s high CAGR.
Key Market Players:
Key players in this market are adopting various organic and inorganic growth strategies, including product launches, agreements, collaborations, acquisitions, and expansions. Prominent players in this market include Drägerwerk AG & Co. KGaA (Germany), GE HealthCare (US), Natus Medical (US), Atom Medical (Japan), Bistos (South Korea), Ningbo David (China), Phothera (US), STRATA Skin Sciences (US), Xuzhou Kernel Medical (China), Shanghai SIGMA High-tech (China), Ultralite Enterprises, Inc. (US), Hoenle Medical GmbH (Germany), Weyer (Germany), Neolight (US), Fanem (Brazil), Phoenix Medical Systems (India), Shenzhen Comen Medical Instruments Co. Ltd. (China), Theralight, Inc. (US), UV Technologies (UK), Curelight (Sweden), Photo Therapeutics Ltd (UK), Tiny Hearts Technology (Nigeria), Lifetrons Inno Equipments Pvt Ltd (India), Ibis Medical Equipment and Systems Pvt Ltd (India), and Sci Health (India).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com